Login / Signup

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment.

Sven van EgmondEsther de VriesLoes HollesteinMaarten BastiaensKees-Peter de RoosDaniëlle KuijpersEwout Willem SteyerbergMarlies WakkeeKlara MosterdTamar NijstenEsther W de Bekker-Grob
Published in: PloS one (2021)
This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • healthcare
  • chronic kidney disease
  • palliative care
  • prognostic factors
  • basal cell carcinoma
  • patient reported outcomes
  • single cell
  • health insurance
  • patient reported